Uremia: Clinical Trials

4 trials for Uremia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 13Unknown 3

Follow Uremia: new trials by email Literature Review of Uremia trials Research Report on Uremia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of SVF Derived MSC in DCD Renal Transplantation
SVFderived MSC transplantations, Basiliximab - Uremia
Phase 1 / Phase 2UnknownFuzhou General Hospital1202014-12-012015-07-08
Clonal Deletion on Living-Relative Donor Kidney Transplantation
donor specific transfusion, MMF, Bortezomib, drugs added according to the immuno condition of the recipients - Renal Transplantation, Uremia
Phase 1 / Phase 2UnknownFuzhou General Hospital152011-03-012011-08-22
Rituximab in Patients With Relapsed or Refractory TTP-HUS
Rituximab - Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome
Phase 2UnknownHamilton Health Sciences Corporation602007-12-012010-05-19
Treatment of Uremic Pruritus by Olive-omega 3 Ointment
application of ointment (olive-omega 3 ointment) - Uremic Pruritus
Phase 1 / Phase 2UnknownAssaf-Harofeh Medical Center202011-10-06

Narrower conditions

Hemolytic-Uremic Syndrome (1)  ·  Pruritus (1)  ·  Purpura, Thrombotic Thrombocytopenic (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Manifestations (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Cytopenia (1)  ·  Hematologic Diseases (1)

Interventions

Basiliximab (1)  ·  Bortezomib (1)  ·  Rituximab (1)

Sponsors

Fuzhou General Hospital (2)  ·  Assaf-Harofeh Medical Center (1)  ·  Hamilton Health Sciences Corporation (1)

Countries

China (2)  ·  Canada (1)

Top investigators

David Barth, MD (1)  ·  Gail Rock, MD (1)  ·  Kathryn E Webert, E (1)  ·  Ronan Foley, MD (1)  ·  Tan Jianming, MD, PhD (1)  ·  Tan Jianming, MD,PhD (1)  ·  William Clark, MD (1)